A Field Study of TY014 in Yellow Fever (YF) Affected Areas of Brazil
Latest Information Update: 02 Dec 2019
Price :
$35 *
At a glance
- Drugs TY 014 (Primary)
- Indications Yellow fever
- Focus Therapeutic Use
- Sponsors Tychan
- 02 Dec 2019 New trial record
- 18 Nov 2019 According to a Tychan media release, Tychan has received regulatory approval in Brazil to conduct a field study in YF affected areas.Dr Mauro Teixeira, Professor of Immunology at the Department of Biochemistry and Immunology, Universidade Federal de Minas Gerais, Brazil, is the principal investigator of this field study for TY014 in Brazil.